{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:40:58Z","timestamp":1764859258133,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":287,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.rmcr.2020.101258","type":"journal-article","created":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T02:28:51Z","timestamp":1603592931000},"page":"101258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Chrysanthi","family":"Sardeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Zarogoulidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Romanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagoula","family":"Oikonomou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Sapalidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Hohenforst-Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosmas","family":"Tsakiridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Zaric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branislav","family":"Perin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Baka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Drevelegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kosmidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoforos","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmcr.2020.101258_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-24223-1_1","article-title":"Lung cancer statistics","volume":"893","author":"Torre","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.rmcr.2020.101258_bib2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.rcl.2012.06.006","article-title":"Lung cancer epidemiology, risk factors, and prevention","volume":"50","author":"de Groot","year":"2012","journal-title":"Radiol. Clin."},{"key":"10.1016\/j.rmcr.2020.101258_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lungcan.2019.11.017","article-title":"Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans","volume":"139","author":"Pinsky","year":"2019","journal-title":"Lung Canc."},{"issue":"1","key":"10.1016\/j.rmcr.2020.101258_bib4","first-page":"7","article-title":"Radial endobronchial ultrasound (EBUS) guided suction catheter-biopsy in histological diagnosis of peripheral pulmonary lesions","volume":"7","author":"Zaric","year":"2016","journal-title":"J. Canc."},{"issue":"Suppl 4","key":"10.1016\/j.rmcr.2020.101258_bib5","first-page":"S359","article-title":"Advanced bronchoscopic techniques in diagnosis and staging of lung cancer","volume":"5","author":"Zaric","year":"2013","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.rmcr.2020.101258_bib6","first-page":"231","article-title":"Cone beam computertomography (CBCT) in interventional chest medicine - high feasibility for endobronchial realtime navigation","volume":"5","author":"Hohenforst-Schmidt","year":"2014","journal-title":"J. Canc."},{"issue":"3","key":"10.1016\/j.rmcr.2020.101258_bib7","first-page":"192","article-title":"Radiation exposure of patients by cone beam CT during endobronchial navigation - a phantom study","volume":"5","author":"Hohenforst-Schmidt","year":"2014","journal-title":"J. Canc."},{"issue":"11","key":"10.1016\/j.rmcr.2020.101258_bib8","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/annonc\/mdt365","article-title":"Assessment of SHOX2 methylation in EBUS-TBNA specimen improves accuracy in lung cancer staging","volume":"24","author":"Darwiche","year":"2013","journal-title":"Ann. Oncol. : official journal of the European Society for Medical Oncology"},{"issue":"4","key":"10.1016\/j.rmcr.2020.101258_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/resp.12489","article-title":"Lung cancer staging now and in the future","volume":"20","author":"Liam","year":"2015","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.rmcr.2020.101258_bib10","first-page":"568","article-title":"Defining the role of tyrosine kinase inhibitors in early stage non-small cell lung cancer","volume":"6","author":"Lampaki","year":"2015","journal-title":"J. Canc."},{"issue":"5","key":"10.1016\/j.rmcr.2020.101258_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/resp.12789","article-title":"Immunotherapy for lung cancer","volume":"21","author":"Steven","year":"2016","journal-title":"Respirology"},{"issue":"2","key":"10.1016\/j.rmcr.2020.101258_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/17474086.2016.1127156","article-title":"Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency","volume":"9","author":"Criscuolo","year":"2016","journal-title":"Expet Rev. Hematol."},{"issue":"10066","key":"10.1016\/j.rmcr.2020.101258_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","article-title":"Lung cancer: current therapies and new targeted treatments","volume":"389","author":"Hirsch","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.rmcr.2020.101258_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ctrv.2019.05.004","article-title":"Management of adverse events associated with tyrosine kinase inhibitors: improving outcomes for patients with hepatocellular carcinoma","volume":"77","author":"Rimassa","year":"2019","journal-title":"Canc. Treat Rev."},{"issue":"10","key":"10.1016\/j.rmcr.2020.101258_bib15","first-page":"997","article-title":"Pembrolizumab in non-small-cell lung cancer","volume":"376","author":"Reck","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.rmcr.2020.101258_bib16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/13696998.2018.1521416","article-title":"Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US","volume":"21","author":"Insinga","year":"2018","journal-title":"J. Med. Econ."},{"issue":"2","key":"10.1016\/j.rmcr.2020.101258_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/imt-2017-0121","article-title":"Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer","volume":"10","author":"Reck","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.rmcr.2020.101258_bib18","first-page":"1","article-title":"Atezolizumab in combination with bevacizumab, paclitaxel and carboplatin for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, including patients with EGFR mutations","author":"Reck","year":"2019","journal-title":"Expet Rev. Respir. Med."},{"issue":"9","key":"10.1016\/j.rmcr.2020.101258_bib19","doi-asserted-by":"crossref","first-page":"FSO421","DOI":"10.2144\/fsoa-2019-0081","article-title":"Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Tun","year":"2019","journal-title":"Future science OA"},{"key":"10.1016\/j.rmcr.2020.101258_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.rmcr.2018.03.001","article-title":"Psoriatic arthritis due to nivolumab administration a case report and review of the literature","volume":"23","author":"Sapalidis","year":"2018","journal-title":"Respiratory medicine case reports"},{"key":"10.1016\/j.rmcr.2020.101258_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.rmcr.2017.10.006","article-title":"Immunotherapy \u201cShock\u201d with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma","volume":"22","author":"Zarogoulidis","year":"2017","journal-title":"Respiratory medicine case reports"},{"key":"10.1016\/j.rmcr.2020.101258_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rmcr.2017.08.017","article-title":"Immunotherapy \u201cShock\u201d a case series of PD-L1 100% and pembrolizumab first-line treatment","volume":"22","author":"Zarogoulidis","year":"2017","journal-title":"Respiratory medicine case reports"},{"key":"10.1016\/j.rmcr.2020.101258_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.rmcr.2017.07.004","article-title":"Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases","volume":"22","author":"Zarogoulidis","year":"2017","journal-title":"Respiratory medicine case reports"},{"key":"10.1016\/j.rmcr.2020.101258_bib24","first-page":"76","article-title":"Managing immune checkpoint-blocking antibody side effects, American Society of Clinical Oncology educational book. American Society of Clinical Oncology","author":"Postow","year":"2015","journal-title":"Annual Meeting"},{"issue":"21","key":"10.1016\/j.rmcr.2020.101258_bib25","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2012.41.6750","article-title":"Management of immune-related adverse events and kinetics of response with ipilimumab","volume":"30","author":"Weber","year":"2012","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"issue":"Suppl 1","key":"10.1016\/j.rmcr.2020.101258_bib26","first-page":"S69","article-title":"[pneumothorax]","volume":"139","author":"Swierzy","year":"2014","journal-title":"Zentralblatt fur Chirurgie"},{"issue":"3","key":"10.1016\/j.rmcr.2020.101258_bib27","first-page":"43","article-title":"Chest drainage systems in use","volume":"3","author":"Zisis","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"3","key":"10.1016\/j.rmcr.2020.101258_bib28","first-page":"41","article-title":"Pneumothorax from diagnosis to treatment, hands on course: Part II","volume":"3","author":"Zarogoulidis","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"11","key":"10.1016\/j.rmcr.2020.101258_bib29","article-title":"Immune-mediated colitis from dual checkpoint inhibitors","volume":"11","author":"Thalambedu","year":"2019","journal-title":"Cureus"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221300712030472X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221300712030472X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:05:15Z","timestamp":1761959115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221300712030472X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":29,"alternative-id":["S221300712030472X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2020.101258","relation":{},"ISSN":["2213-0071"],"issn-type":[{"type":"print","value":"2213-0071"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute pneumothorax due to immunotherapy administration in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2020.101258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101258"}}